Egle Therapeutics Appoints John Celebi as Chief Executive Officer

Go back to Egle Therapeutics Appoints John Celebi as Chief Executive Officer
(NASDAQ: SNSE) Delayed: 13.85 --0 (-0%)
Previous Close $13.85    52 Week High
Open $13.85    52 Week Low
Day High $13.85    P/E N/A 
Day Low $13.85    EPS
Volume 2,927,143